News

MariEnergies launches project to turn waste emissions into LNG

Mari Energies Limited, one of Pakistan’s largest E&P companies, has partnered with Ghani Chemical Industries Limited (GCIL) to establish a special purpose vehicle (SPV) aimed at converting waste gases into commercially viable products, including liquefied natural gas (LNG) and carbon dioxide. The listed company disclosed the development in a notice to the Pakistan Stock Exchange (PSX). “Mari

Buying returns to bourse, KSE-100 up over 2,200 points

A day after intense selling pressure, buying momentum returned at the Pakistan Stock Exchange (PSX), with the benchmark KSE-100 Index gaining over 2,200 points during the opening minutes of trading on Tuesday. At 9:35am, the benchmark index was hovering at 149,106.44, up by 2,263.47 or 1.54%. Buying was observed in key sectors, including automobile assemblers, cement, commercial banks, oil a

Jazz, VEON unveil USD1bn investment plan

In a major boost to Pakistan’s digital future, Jazz and VEON leadership unveiled an ambitious USD 1 billion investment plan in a high-level meeting with the finance minister to expand connectivity, modernise infrastructure, and accelerate digital innovation across the country. JazzWorld CEO Aamir Ibrahim, accompanied by VEON Group CEO Kaan Terzioglu and senior leadership, held a high-level meet

Brent crude set for record monthly gain; Asia shares falter as Iran war rages

Oil prices on Tuesday were set for a record monthly rise while Asian shares were headed for their steepest fall since 2022, ​capping a tumultuous month as the war in the Middle East stoked fears of higher inflation and slower growth. Bonds were headed for their ‌largest decline in months, owing to the hawkish sea change in the global outlook for interest rates, while the dollar recorded its str

Pharma sector: Leading Russian insulin maker to invest USD80m

The leading Russian pharmaceutical company M/s Genetics Pharmaceuticals/M/s Zavod Medsintez LLC, producing insulin, will invest approximately USD80 million in Pakistan’s pharma sector over the next six years. In this connection, the Drug Regulatory Authority of Pakistan (DRAP) has conditionally fixed the Maximum Retail Price (MRP) for six insulin products of the Russian pharmaceutical company,